The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis

The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis

Abstract Background The role of adjuvant chemotherapy (AC) in stage III rectal cancer (RC) has been argued based on evidence from its use in colon cancer. Previous trials have analysed disease-free and overall survivals as endpoints, rather than disease recurrence. This study compares the competing...

Full description

Bibliographic Details
Main Authors: Kheng-Seong Ng, Charles Chan, Matthew John Francis Xavier Rickard, Anil Keshava, Peter Stewart, Pierre Henri Chapuis
Format: Article
Language:English
Published: BMC 2023-05-01
Series:World Journal of Surgical Oncology
Subjects:
Rectal cancer
Adjuvant chemotherapy
Disease recurrence
Cancer-specific death
Competing risks analysis
Online Access:https://doi.org/10.1186/s12957-023-03021-w

Internet

https://doi.org/10.1186/s12957-023-03021-w

Similar Items